Healthcare
·
Drug Manufacturers - General
LLY remains close to its 52-week high with an active weekly Trend Signal, but lighter participation and cooling Market Dynamics make the setup more balanced than the price chart alone suggests.
Healthcare
·
Drug Manufacturers - General
MRK added 2.8% in the latest week and remains in an active weekly Trend Signal, but participation was only 0.8x its 13-week average as the stock trades well above Fair Value.
Healthcare
·
Drug Manufacturers - Specialty & Generic
NBIX closed at $175.8, just 3.0% below its 52-week high, with an active weekly Trend Signal and positive Market Dynamics. The reservation is participation, with latest volume at only 1.0x the 13-week average.
Healthcare
·
Biotechnology
INCY finished at $117.70, just 1.6% below its 52-week high, with an active Trend backdrop and positive Market Dynamics, but the latest move came on only 0.8x 13-week volume.
Healthcare
·
Diagnostics & Research
Natera remains in an active weekly Trend Signal after a 33.2% 12-week advance, but the latest gain came on lighter participation and a large Fair Value premium.
Healthcare
·
Drug Manufacturers - General
BMY added 5.5% in the latest week and led its US Drug Manufacturers - General group, but Sharemaestro Market Dynamics have not fully confirmed the move.
Healthcare
·
Biotechnology
RPRX rose 3.1% in a down week for Healthcare and sits just 2.1% below its 52-week high, but volume at 0.7x the 13-week average keeps confirmation less than emphatic.
Healthcare
·
Biotechnology
JAZZ closed just 1.2% below its 52-week high after a 26.0% quarter, but the latest advance came on only 0.7x normal volume and activity pressure has cooled from June levels.
Healthcare
·
Drug Manufacturers - General
BIIB rose 3.4% in the latest week on nearly double its 13-week volume, keeping a 45-week Trend Signal intact while Healthcare breadth remains selective.
Healthcare
·
Drug Manufacturers - General
JNJ slipped 1.5% in the latest week, but the broader profile remains constructive, with the stock still 8.7% above its weekly Trend Line and 85.2% through its 52-week range.
Healthcare
·
Diagnostics & Research
GH remains in an active weekly trend after a powerful three-month move, though last week’s 4.7% pullback and only modest volume confirmation leave the next phase more selective.
Healthcare
·
Biotechnology
ROIV added 2.4% for the week and remains within 2.8% of its 52-week high, with biotechnology breadth supportive but volume confirmation still measured.
Healthcare
·
Biotechnology
RVMD remains in an active weekly Trend Signal and close to its 52-week peak, but the latest pullback came with participation at just 0.5x the 13-week average.
Healthcare
·
Biotechnology
BBIO rose 11.3% in the latest week and now sits 19.3% above its weekly Trend Line, with participation twice its 13-week norm. The caution is that Sharemaestro’s Trend Signal remains inactive and the stock is trading at a large premium to co
Healthcare
·
Healthcare Plans
CVS Health closed at $104.2, only 1.9% below its 52-week peak, but the latest weekly move lacked volume confirmation and relative strength has cooled over four weeks.